roxane: impact of 21-gene assay on treatment for early breast cancer
Published 4 years ago • 133 plays • Length 5:54Download video MP4
Download video MP3
Similar videos
-
0:38
rxponder: 21-gene assay informs chemotherapy benefit in hr node-positive breast cancer
-
0:55
the clinical impact of gene expression assays on early luminal breast cancer
-
0:40
assessing the role of 21-gene assays in breast cancer
-
0:53
prognostic trials for 21-gene oncotypedx in hr /her2- breast cancer with micrometastases
-
5:34
tailorx: phase 3 trial validating a 21-gene expression assay in breast cancer
-
0:38
the role of the oncotype dx assay in the management of patients with breast cancer
-
2:13
n9831 trial: genes associated with early and late recurrence in her2 breast cancer
-
0:49
breast cancer breakthroughs why survival rates are higher than ever
-
6:23
stratifying patients with breast cancer by a 7-gene assay for endocrine therapy
-
2:35
treatment options for high risk early breast cancer
-
2:14
survival in premenopausal hr /her2- breast cancer with micro-metastasis and 21-gene score
-
18:14
does 21-gene recurrence score assay testingchange decisions? dr. adher alsayed ( day 1)
-
14:21
genomic testing during breast cancer: should you have testing?
-
1:05
clinical impact of positive trial
-
3:18
5-year outcomes from planb: phase 3 trial of 21-gene recurrence score® result in breast cancer
-
30:56
adjuvant treatment for early stage hormone positive breast cancer: role of genomic signatures
-
4:11
the latest in neo-adjuvant therapy for luminal breast cancer
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
1:28
dr. soliman on impact of mammaprint in patients with early-stage breast cancer